Cargando…
Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson’s Disease (PD)
Magnetic resonance imaging (MRI) has the potential to serve as a biomarker for Parkinson’s disease (PD). However, the type or types of biomarker it could provide remain to be determined. At this time there is not sufficient sensitivity or specificity for MRI to serve as an early diagnostic biomarker...
Autor principal: | Tuite, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483641/ https://www.ncbi.nlm.nih.gov/pubmed/28621758 http://dx.doi.org/10.3390/brainsci7060068 |
Ejemplares similares
-
Magnetic Resonance Imaging (MRI) in Parkinson’s Disease
por: Tuite, Paul J, et al.
Publicado: (2013) -
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease
por: Sulzer, David, et al.
Publicado: (2018) -
Parkinson's disease and atypical parkinsonism: the importance of
magnetic resonance imaging as a potential biomarker
por: Carrete Jr., Henrique
Publicado: (2017) -
Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson's Disease?
por: Ciurleo, Rosella, et al.
Publicado: (2014) -
Magnetic Resonance Imaging Biomarkers of Punding in Parkinson’s Disease
por: Mao, Chenglu, et al.
Publicado: (2023)